BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10640453)

  • 21. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial.
    Desneves KJ; Todorovic BE; Cassar A; Crowe TC
    Clin Nutr; 2005 Dec; 24(6):979-87. PubMed ID: 16297506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of pressure ulcers: 20-year experience.
    Schryvers OI; Stranc MF; Nance PW
    Arch Phys Med Rehabil; 2000 Dec; 81(12):1556-62. PubMed ID: 11128889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional status and wound severity of overweight and obese patients with venous leg ulcers: a pilot study.
    Tobón J; Whitney JD; Jarrett M
    J Vasc Nurs; 2008 Jun; 26(2):43-52. PubMed ID: 18492557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune depression syndrome following human spinal cord injury (SCI): a pilot study.
    Riegger T; Conrad S; Schluesener HJ; Kaps HP; Badke A; Baron C; Gerstein J; Dietz K; Abdizahdeh M; Schwab JM
    Neuroscience; 2009 Feb; 158(3):1194-9. PubMed ID: 18790013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Australian experience of managing pressure ulcers in persons with SCI.
    Wellard SJ
    SCI Nurs; 2001; 18(1):11-7. PubMed ID: 12035472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte function in wound healing and following injury.
    Schäffer M; Barbul A
    Br J Surg; 1998 Apr; 85(4):444-60. PubMed ID: 9607524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
    Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
    Keast DH; Fraser C
    Ostomy Wound Manage; 2004 Oct; 50(10):64-70. PubMed ID: 15509883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury.
    Lü HZ; Xu L; Zou J; Wang YX; Ma ZW; Xu XM; Lu PH
    Brain Behav Immun; 2008 Nov; 22(8):1217-30. PubMed ID: 18625299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anesthetic requirements and stress hormone responses in spinal cord-injured patients undergoing surgery below the level of injury.
    Yoo K; Hwang J; Jeong S; Kim S; Bae H; Choi J; Chung S; Lee J
    Anesth Analg; 2006 Apr; 102(4):1223-8. PubMed ID: 16551927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional status during the acute stage of spinal cord injury.
    Laven GT; Huang CT; DeVivo MJ; Stover SL; Kuhlemeier KV; Fine PR
    Arch Phys Med Rehabil; 1989 Apr; 70(4):277-82. PubMed ID: 2930340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of blood and serum markers in spinal cord injured patients with pressure sores.
    Gurcay E; Bal A; Gurcay AG; Cakci A
    Saudi Med J; 2009 Mar; 30(3):413-7. PubMed ID: 19271073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Medihoney as a non-surgical therapy for chronic pressure ulcers in patients with spinal cord injury.
    Biglari B; vd Linden PH; Simon A; Aytac S; Gerner HJ; Moghaddam A
    Spinal Cord; 2012 Feb; 50(2):165-9. PubMed ID: 21931331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management.
    Walter JS; Sacks J; Othman R; Rankin AZ; Nemchausky B; Chintam R; Wheeler JS
    J Rehabil Res Dev; 2002; 39(1):53-61. PubMed ID: 11926327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting "charge outliers" after spinal cord injury: a multicenter analysis of demographics, injury characteristics, outcomes, and rehabilitation charges.
    Burnett DM; Cifu DX; Kolakowsky-Hayner S; Kreutzer JS
    Arch Phys Med Rehabil; 2001 Jan; 82(1):114-9. PubMed ID: 11239296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cellular inflammatory response in human spinal cords after injury.
    Fleming JC; Norenberg MD; Ramsay DA; Dekaban GA; Marcillo AE; Saenz AD; Pasquale-Styles M; Dietrich WD; Weaver LC
    Brain; 2006 Dec; 129(Pt 12):3249-69. PubMed ID: 17071951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of serum T-lymphocyte subsets and NK cell activity in patients with hypopharyngeal squamous cell carcinoma].
    Chen WK; Song M; Chen FJ; Guo ZM; He LR; Yan SL
    Ai Zheng; 2006 Oct; 25(10):1300-2. PubMed ID: 17059781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relation between serum MDA and cystatin C levels in chronic spinal cord injury patients.
    Koçak H; Oner-Iyidoğan Y; Gürdöl F; Koçak T; Esin D
    Clin Biochem; 2005 Nov; 38(11):1034-7. PubMed ID: 16154555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
    Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.